{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:56:18Z","timestamp":1790873778447,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.pharma.2024.04.001","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T08:21:49Z","timestamp":1712650909000},"page":"813-821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development of mucoadhesive microspheres for intranasal delivery of fluconazole as an alternative treatment of cryptococcal meningitis infection in patients with acquired immunodeficiency"],"prefix":"10.1016","volume":"82","author":[{"given":"Amriani","family":"Sapra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrawan","family":"Hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayyid M.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Syahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filia Ananda","family":"Kelsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syamsu","family":"Nur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andi Dian","family":"Permana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2024.04.001_bib0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11910-019-0993-0","article-title":"New insights into cryptococcus Spp. biology and cryptococcal meningitis","volume":"10","author":"Temfack","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"10.1016\/j.pharma.2024.04.001_bib0175","doi-asserted-by":"crossref","first-page":"8","DOI":"10.55175\/cdk.v48i1.1256","article-title":"Meningitis Kriptokokus pada Penderita HIV","volume":"48","author":"Wijaya","year":"2021","journal-title":"Cermin Dunia Kedokt"},{"issue":"2","key":"10.1016\/j.pharma.2024.04.001_bib0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281580","volume":"18","author":"Lalloo","year":"2023","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.pharma.2024.04.001_bib0185","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s40265-022-01757-5","article-title":"Treatment of cryptococcal meningitis: how have we got here and where are we going?","volume":"82","author":"Ngan","year":"2022","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.pharma.2024.04.001_bib0190","doi-asserted-by":"crossref","first-page":"e2338","DOI":"10.1093\/cid\/ciaa1544","article-title":"Antifungal susceptibility does not correlate with fungal clearance or survival in AIDS-associated cryptococcal meningitis","volume":"73","author":"O\u2019Connor","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.pharma.2024.04.001_bib0195","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/S1473-3099(18)30493-6","article-title":"Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries","volume":"19","author":"Loyse","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.pharma.2024.04.001_bib0200","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3390\/jof8111157","article-title":"Fluconazole failure in the treatment of coccidioidal meningitis","volume":"8","author":"Gupta","year":"2022","journal-title":"J Fungi"},{"issue":"12","key":"10.1016\/j.pharma.2024.04.001_bib0205","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMoa2111904","article-title":"Single-dose liposomal amphotericin B treatment for cryptococcal meningitis","volume":"386","author":"Jarvis","year":"2022","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.pharma.2024.04.001_bib0210","doi-asserted-by":"crossref","first-page":"e0225742","DOI":"10.1371\/journal.pone.0225742","article-title":"Pathways to care and outcomes among hospitalised HIV-seropositive persons with cryptococcal meningitis in South Africa","volume":"14","author":"Quan","year":"2019","journal-title":"PLOS One"},{"key":"10.1016\/j.pharma.2024.04.001_bib0215","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/IDR.S118892","article-title":"Fluconazole Resistance in Candida Species: a Current Perspective","volume":"10","author":"Elizabeth","year":"2017","journal-title":"Infection and Drug Resistence"},{"issue":"7","key":"10.1016\/j.pharma.2024.04.001_bib0220","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1586\/era.10.77","article-title":"Intranasal fentanyl: from pharmacokinetics and bioavailability to current treatment applications","volume":"10","author":"Panagiotou","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"10.1016\/j.pharma.2024.04.001_bib0225","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMra1816149","article-title":"Drug-induced liver injury \u2014 types and phenotypes","volume":"381","author":"Hoofnagle","year":"2019","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.pharma.2024.04.001_bib0230","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s40263-022-00930-4","article-title":"Using the intranasal route to administer drugs to treat neurological and psychiatric illnesses: rationale, successes, and future needs","volume":"36","author":"Lofts","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharma.2024.04.001_bib0235","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2017.11.041","article-title":"Nanoparticulate peptide delivery exclusively to the brain produces tolerance free analgesia","volume":"270","author":"Godfrey","year":"2018","journal-title":"J Controlled Release"},{"issue":"08","key":"10.1016\/j.pharma.2024.04.001_bib0240","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/a-1193-4781","article-title":"Development of nasal mucoadhesive microspheres of granisetron: a potential drug","volume":"70","author":"Pandey","year":"2020","journal-title":"Drug Res"},{"key":"10.1016\/j.pharma.2024.04.001_bib0245","doi-asserted-by":"crossref","first-page":"981","DOI":"10.52711\/0974-360X.2022.00164","article-title":"Formulation and characterization of mucoadhesive Microspheres of Aceclofenac","author":"Venkata Gopaiah","year":"2022","journal-title":"Res J Pharm Technol"},{"key":"10.1016\/j.pharma.2024.04.001_bib0250","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jconrel.2022.09.024","article-title":"Mucoadhesive carriers for oral drug delivery","volume":"351","author":"Kumar","year":"2022","journal-title":"J Controlled Release"},{"key":"10.1016\/j.pharma.2024.04.001_bib0255","article-title":"Microspheres for Targetted Drug Delivery- A Review on Recent Aplication","volume":"75","author":"Ankita","year":"2022","journal-title":"J. of Drug Delivery Science and Technology"},{"issue":"1","key":"10.1016\/j.pharma.2024.04.001_bib0260","doi-asserted-by":"crossref","first-page":"406","DOI":"10.32628\/IJSRST2310155","article-title":"Microsphere A Novel Drug Delivery System \u2013 A Review","volume":"10","author":"Mohammad","year":"2023","journal-title":"Int J Sci Res Sci Technol"},{"key":"10.1016\/j.pharma.2024.04.001_bib0265","series-title":"447.\u00a0Beyond scenarios\u2013resource optimization for dairy cattle breeding programs (MoBPSopti)","first-page":"1860","author":"Hassanpour","year":"2022"},{"issue":"2","key":"10.1016\/j.pharma.2024.04.001_bib0270","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/0250-474X.33151","article-title":"Microencapsulation of zidovudine by double emulsion solvent diffusion technique using ethylcellulose","volume":"69","author":"Das","year":"2007","journal-title":"Indian J Pharm Sci"},{"issue":"11","key":"10.1016\/j.pharma.2024.04.001_bib0275","first-page":"630","article-title":"Formulation and Evaluation of microsphere of Rebiprazole Sodium","volume":"12","author":"Priya","year":"2023","journal-title":"Eur Chem Bull"},{"issue":"2","key":"10.1016\/j.pharma.2024.04.001_bib0280","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/02652040310001637811","article-title":"Fluconazole encapsulation in PLGA microspheres by spray-drying","volume":"21","author":"Rivera","year":"2004","journal-title":"J Microencapsul"},{"issue":"1","key":"10.1016\/j.pharma.2024.04.001_bib0285","article-title":"Sadono, Melinda Natalia Suwito, Pengembangan Mikrosfer Asiklovir menggunakan Kitosan dan Natrium Tripolifosfat: Faktor Suhu Inlet","volume":"4","author":"Muntu","year":"2022","journal-title":"Keluwih J Kesehat Dan Kedokt"},{"key":"10.1016\/j.pharma.2024.04.001_bib0290","doi-asserted-by":"crossref","first-page":"34","DOI":"10.22159\/ijcpr.2019v11i4.34941","article-title":"Microsphere a drug delivery system\u2013a review","volume":"1","author":"Das","year":"2019","journal-title":"Int J Curr Pharm Res"},{"issue":"2","key":"10.1016\/j.pharma.2024.04.001_bib0295","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0976-0105.177705","article-title":"Fabrication, characterization, and evaluation of microsponge delivery system for facilitated fungal therapy","volume":"7","author":"Moin","year":"2016","journal-title":"J Basic Clin Pharm"},{"issue":"2","key":"10.1016\/j.pharma.2024.04.001_bib0300","doi-asserted-by":"crossref","first-page":"497","DOI":"10.33786\/JCPR.2012.v02i02.006","article-title":"Formulation and evaluation of mucoadhesive microspheres of ziprasidone hydrochloride for oral controlled release","volume":"2","author":"Deshmukh","year":"2012","journal-title":"Curr Pharma Res"},{"issue":"7","key":"10.1016\/j.pharma.2024.04.001_bib0305","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/aor.13887","article-title":"Complement activation by dialysis membranes and its association with secondary membrane formation and surface charge","volume":"45","author":"Melchior","year":"2021","journal-title":"Artif Organs"},{"issue":"1\u20133","key":"10.1016\/j.pharma.2024.04.001_bib0310","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.colsurfa.2011.07.032","article-title":"Evaluation of dialysis membrane process for quantifying the in vitro drug-release from colloidal drug carriers","volume":"389","author":"Moreno-Bautista","year":"2011","journal-title":"Colloids Surf Physicochem Eng Asp"},{"issue":"1","key":"10.1016\/j.pharma.2024.04.001_bib0315","first-page":"8","article-title":"An over view: Microspheres as a nasal drug delivery system","volume":"5","author":"Chaudhari","year":"2010","journal-title":"International Journal and Pharmaceutical Science"},{"key":"10.1016\/j.pharma.2024.04.001_bib0320","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1038\/s41598-018-23064-4","article-title":"Parameters Influencing The Size of Chitosan-TPP Nano- and Microparcticle","volume":"8","author":"Sruthi","year":"2018","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/j.pharma.2024.04.001_bib0325","first-page":"1","article-title":"Effect of chitosan and atenolol ratio on size diameter, sorption efficiency and release profile in atenolol microsphere formula by emulsification method","volume":"4","author":"Ashri","year":"2019","journal-title":"Pharmaceutical Journal of Indonesia"},{"issue":"1","key":"10.1016\/j.pharma.2024.04.001_bib0330","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/00137696-200402010-00003","article-title":"Factors affecting mechanism and kinetics of drug release from matrix-based oral controlled drug delivery systems","volume":"2","author":"Varma","year":"2004","journal-title":"Am J Drug Deliv"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450924000464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450924000464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T20:33:42Z","timestamp":1724963622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450924000464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0003450924000464"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2024.04.001","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of mucoadhesive microspheres for intranasal delivery of fluconazole as an alternative treatment of cryptococcal meningitis infection in patients with acquired immunodeficiency","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2024.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}